Achmea Investment Management B.V. trimmed its position in shares of Xylem Inc. (NYSE:XYL – Free Report) by 11.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 300,534 shares of the industrial products company’s stock after selling 39,955 shares during the quarter. Achmea Investment Management B.V. owned approximately 0.12% of Xylem worth $44,329,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in Xylem by 0.7% in the third quarter. Vanguard Group Inc. now owns 29,902,236 shares of the industrial products company’s stock valued at $4,410,580,000 after buying an additional 204,407 shares in the last quarter. State Street Corp increased its position in shares of Xylem by 1.2% in the third quarter. State Street Corp now owns 10,953,206 shares of the industrial products company’s stock valued at $1,615,598,000 after buying an additional 133,173 shares in the last quarter. Amundi raised its stake in shares of Xylem by 17.0% during the 2nd quarter. Amundi now owns 5,714,576 shares of the industrial products company’s stock worth $730,717,000 after buying an additional 830,337 shares during the period. Swedbank AB raised its stake in shares of Xylem by 19.0% during the 3rd quarter. Swedbank AB now owns 5,197,753 shares of the industrial products company’s stock worth $766,669,000 after buying an additional 830,821 shares during the period. Finally, Invesco Ltd. lifted its position in shares of Xylem by 4.3% during the 2nd quarter. Invesco Ltd. now owns 4,056,072 shares of the industrial products company’s stock valued at $524,694,000 after buying an additional 166,959 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.
Xylem Price Performance
Shares of NYSE:XYL opened at $121.74 on Wednesday. Xylem Inc. has a 12 month low of $100.47 and a 12 month high of $154.27. The firm has a market capitalization of $29.60 billion, a P/E ratio of 31.06, a P/E/G ratio of 1.73 and a beta of 1.17. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.62 and a quick ratio of 1.28. The company’s fifty day moving average price is $133.22 and its 200 day moving average price is $139.54.
Xylem Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 24th. Shareholders of record on Tuesday, February 24th will be paid a $0.43 dividend. This is an increase from Xylem’s previous quarterly dividend of $0.40. This represents a $1.72 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Tuesday, February 24th. Xylem’s dividend payout ratio (DPR) is presently 43.88%.
Xylem declared that its Board of Directors has initiated a share repurchase program on Wednesday, February 25th that allows the company to buyback $1.50 billion in outstanding shares. This buyback authorization allows the industrial products company to purchase up to 4.8% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s management believes its stock is undervalued.
Analyst Upgrades and Downgrades
Several brokerages recently commented on XYL. Barclays cut their price target on shares of Xylem from $166.00 to $156.00 and set an “overweight” rating for the company in a report on Wednesday, February 11th. Stifel Nicolaus decreased their price objective on shares of Xylem from $178.00 to $175.00 and set a “buy” rating on the stock in a report on Wednesday, February 11th. Citigroup dropped their target price on shares of Xylem from $182.00 to $174.00 and set a “buy” rating on the stock in a research report on Wednesday, February 11th. Oppenheimer set a $165.00 target price on shares of Xylem in a research note on Thursday, February 12th. Finally, Robert W. Baird set a $161.00 price target on shares of Xylem in a research report on Wednesday, February 11th. Nine research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $158.08.
View Our Latest Research Report on Xylem
Xylem Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Featured Stories
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
